Search research articles
Contact Us
Filters
Showing results (1-10 of 139) with videos related to
Page
of 14
Sort By:
Nature Medicine
|
April 18, 2024
Targeting KRAS in cancer
Anupriya Singhal, Bob T Li, Eileen M O'Reilly
Journal of Clinical Medicine
|
August 4, 2015
Treatment and Prevention of Bone Metastases from Breast Cancer: A Comprehensive Review of Evidence for Clinical Practice
Bob T Li, Matthew H Wong, Nick Pavlakis
The Journal of Thoracic and Cardiovascular Surgery
|
April 5, 2018
Circulating tumor DNA: A promising biomarker to guide postoperative treatment and surveillance of non-small cell lung cancer
James M Isbell, David R Jones, Bob T Li
The Journal of Thoracic and Cardiovascular Surgery
|
June 20, 2021
The emerging role of local therapy in oligometastatic non-small cell lung cancer
James M Isbell, Bob T Li, Daniel R Gomez
The New England Journal of Medicine
|
May 4, 2022
Trastuzumab Deruxtecan in Non-Small-Cell Lung Cancer. Reply
Bob T Li, Egbert F Smit, Pasi A Jänne
Journal of Thoracic Disease
|
January 12, 2019
Liquid biopsy guided precision therapy for lung cancers
Chongrui Xu, Michael Offin, Paul K Paik, et al.
Annals of Translational Medicine
|
June 9, 2016
What does the future hold for immunotherapy in cancer?
Jarushka Naidoo, Bob T Li, Katja Schindler, et al.
Cancer
|
April 2, 2025
Targeting HER2 in lung cancers: Evolving treatment landscape and drug development strategies
Daniel Reinhorn, Mor Moskovitz, William D Tap, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 6, 2024
A Promising Step Forward With Giant Leaps Ahead
Narek Shaverdian, Bob T Li, James Isbell, et al.
Therapeutics and Clinical Risk Management
|
July 28, 2018
Entrectinib: an orally available, selective tyrosine kinase inhibitor for the treatment of <i>NTRK</i>, <i>ROS1</i>, and <i>ALK</i> fusion-positive solid tumors
Dazhi Liu, Michael Offin, Stephen Harnicar, et al.
Page
of 14
Search research articles
Search
Showing results (1-10 of 139) with videos related to
Sort By:
Page
of 14
Nature Medicine
|
April 18, 2024
Targeting KRAS in cancer
Anupriya Singhal, Bob T Li, Eileen M O'Reilly
Journal of Clinical Medicine
|
August 4, 2015
Treatment and Prevention of Bone Metastases from Breast Cancer: A Comprehensive Review of Evidence for Clinical Practice
Bob T Li, Matthew H Wong, Nick Pavlakis
The Journal of Thoracic and Cardiovascular Surgery
|
April 5, 2018
Circulating tumor DNA: A promising biomarker to guide postoperative treatment and surveillance of non-small cell lung cancer
James M Isbell, David R Jones, Bob T Li
The Journal of Thoracic and Cardiovascular Surgery
|
June 20, 2021
The emerging role of local therapy in oligometastatic non-small cell lung cancer
James M Isbell, Bob T Li, Daniel R Gomez
The New England Journal of Medicine
|
May 4, 2022
Trastuzumab Deruxtecan in Non-Small-Cell Lung Cancer. Reply
Bob T Li, Egbert F Smit, Pasi A Jänne
Journal of Thoracic Disease
|
January 12, 2019
Liquid biopsy guided precision therapy for lung cancers
Chongrui Xu, Michael Offin, Paul K Paik, et al.
Annals of Translational Medicine
|
June 9, 2016
What does the future hold for immunotherapy in cancer?
Jarushka Naidoo, Bob T Li, Katja Schindler, et al.
Cancer
|
April 2, 2025
Targeting HER2 in lung cancers: Evolving treatment landscape and drug development strategies
Daniel Reinhorn, Mor Moskovitz, William D Tap, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 6, 2024
A Promising Step Forward With Giant Leaps Ahead
Narek Shaverdian, Bob T Li, James Isbell, et al.
Therapeutics and Clinical Risk Management
|
July 28, 2018
Entrectinib: an orally available, selective tyrosine kinase inhibitor for the treatment of <i>NTRK</i>, <i>ROS1</i>, and <i>ALK</i> fusion-positive solid tumors
Dazhi Liu, Michael Offin, Stephen Harnicar, et al.
Page
of 14